Registered entities
Avera Pharmaceuticals, Inc.
Reg. No. 10626499Belgium
Investor mix
11 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 4 | 36% |
| Other / undisclosed | 2 | 18% |
Small molecule drugs for the treatment of diseases affecting the central nervous system (CNS)
11 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 4 | 36% |
| Other / undisclosed | 2 | 18% |